Kanser Genetiği ve Kişiye Özel Onkoloji Çözümleri | Onkogenoks
February 3, 2023
Bebeğin cinsiyeti kaçıncı ayda belli olur?
May 30, 2023Kanser Genetiği ve Kişiye Özel Onkoloji Çözümleri | Onkogenoks
February 3, 2023Bebeğin cinsiyeti kaçıncı ayda belli olur?
May 30, 2023
What Is NIPT?
What Is the NIPT Test?
NIPT (Non-Invasive Prenatal Test) is a non-invasive prenatal screening test that analyzes cell-free fetal DNA (cfDNA) circulating in the maternal bloodstream to provide information about the baby’s chromosomal health. NIPT is widely preferred for detecting chromosomal abnormalities related to chromosome number, particularly Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome), with a high level of accuracy. This test can be performed from the 10th week of pregnancy and requires only a single blood sample, posing no risk to either the mother or the baby.
RapidNIPT is the NIPT service brand offered by Genoks Genetic Disorders Evaluation Center. All processes of the RapidNIPT test are carried out in Genoks’ fully automated, high-technology laboratories in Ankara. Developed using advanced genetic analysis systems adopted from leading global technologies, RapidNIPT provides a safe, comprehensive, and scientifically grounded prenatal screening experience. With RapidNIPT, families can make more informed decisions during pregnancy and gain early insights into potential risks.
What is RapidNIPT?
RapidNIPT is a specialized NIPT test brand offered by the Genoks Genetic Disorders Evaluation Center. All analyses are performed using advanced high-technology systems within fully automated laboratory infrastructure in Ankara. The process is conducted in accordance with high sensitivity and reliability standards, using methods that minimize human intervention.
RapidNIPT makes the genetic evaluation process patient-oriented, fast, and practical. Test results are interpreted by experienced medical genetics specialists and delivered to families with professional consultation.
How Is the RapidNIPT Test Performed?
The RapidNIPT test can be performed starting from the 10th week of pregnancy. The procedure is simple:
- A single tube of blood is drawn from the mother’s arm, similar to a routine blood test.
- cfDNA (cell-free DNA) present in the blood sample is analyzed. cfDNA is genetic material that passes from the placenta into the mother’s bloodstream during pregnancy and provides information about the fetus.
- The cfDNA is examined using advanced molecular analysis techniques.
This enables the evaluation of fetal genetic data and allows for risk assessment of chromosomal abnormalities.
Down Syndrome and NIPT
The NIPT test is a reliable method particularly used for assessing common chromosomal abnormalities such as Down syndrome (Trisomy 21). Down syndrome occurs due to an extra copy of chromosome 21 and is one of the most frequently observed chromosomal variations during pregnancy.
RapidNIPT provides valuable information to families by evaluating the risk of Down syndrome. In addition, it can also assess other chromosomal abnormalities such as Trisomy 18 and Trisomy 13.
RapidNIPT and cfDNA Analysis
The focus of the RapidNIPT test is cfDNA found in maternal blood. cfDNA naturally circulates during pregnancy and reflects the genetic structure of the fetus. With this modern method, risk assessment is performed without any invasive procedure, ensuring a safe process for both the mother and the baby.
Advantages of RapidNIPT
- Non-invasive method: Requires only a blood sample.
- Early applicability: Can be performed from the 10th week of pregnancy.
- Comprehensive screening: Evaluates Down syndrome and other chromosomal abnormalities.
- Fast results: Risk assessment is completed in a short time.
- Expert support: Results are interpreted by medical genetics specialists.
Frequently Asked Questions
What is the NIPT test and what is its purpose?
NIPT (Non-Invasive Prenatal Test) is based on the analysis of cfDNA in maternal blood and provides screening information for specific chromosomal abnormalities such as Down syndrome.
From which week can the NIPT test be performed?
It is generally performed from the 10th week of pregnancy. Suitability should be evaluated by a physician based on individual circumstances.
Is NIPT an invasive procedure?
No. It is performed using only a blood sample and is a non-invasive screening method.
Which chromosomal abnormalities does the NIPT test evaluate?
It primarily evaluates common autosomal aneuploidies such as Down syndrome (Trisomy 21), as well as Trisomy 18 and Trisomy 13, along with >7 Mb deletion/duplication syndromes, sex chromosome aneuploidies, and additionally DiGeorge syndrome within the PLUS panel.
How accurate is the NIPT test?
It has a high accuracy rate; however, it is a screening test and provides risk assessment rather than a definitive diagnosis. Diagnostic tests may be recommended if necessary.
How long does it take to receive results?
RapidNIPT results are reported within 3 to 5 business days, while RapidNIPTPlus results are typically available within 7 to 10 business days.
In which cases might results not be obtained?
Low fetal fraction in early weeks, multiple pregnancies, or technical factors may affect the results. In such cases, a repeat sample may be requested.
What is RapidNIPT?
RapidNIPT is Genoks’ NIPT brand. It provides cfDNA-based non-invasive screening, and results are evaluated by medical genetics specialists together with clinical information.
